Skip to main content
. 2022 May 26;2022(5):CD013506. doi: 10.1002/14651858.CD013506.pub2

Comparison 2. Nebulised magnesium sulfate + standard care versus placebo + standard care.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Proportion of people with hospital admissions (from the emergency room) 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
2.2 Proportion of people who need ICU admission 2 281 Odds Ratio (M‐H, Random, 95% CI) 0.39 [0.15, 1.00]
2.3 Proportion of people who need ventilatory support (non‐invasive ventilation or assisted ventilation) 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
2.4 Length of hospital stay (days) 1   Mean Difference (IV, Random, 95% CI) Totals not selected
2.5 All‐cause mortality 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
2.6 FEV 1 at 60 min (L) 1   Mean Difference (IV, Random, 95% CI) Totals not selected
2.7 PEFR change from baseline at 60 min (L/min) 1   Mean Difference (IV, Random, 95% CI) Totals not selected
2.8 PEFR at 60 min (L/min) 1   Mean Difference (IV, Random, 95% CI) Totals not selected
2.9 Change in dyspnoea score 1   Mean Difference (IV, Random, 95% CI) Totals not selected
2.10 Change in SaO 2 (%) 1   Mean Difference (IV, Random, 95% CI) Totals not selected